Chronic pain and pain medication use in chronic obstructive pulmonary disease: A cross-sectional study

Annals of the American Thoracic Society

Volumn 10, Issue 4, 2013, Pages 290-298

  Roberts, Melissa H ^a   Mapel, Douglas W ^a   Hartry, Ann ^b   Von Worley, Ann ^a   Thomson, Heather ^b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b Health Economics and Outcomes Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; OPIATE; SEDATIVE AGENT;

ADULT; AGED; ANALGESIA; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PAIN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ETHNICITY; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PREVALENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SPIROMETRY; UNITED STATES;

ADULT; AGED; ANALGESICS, OPIOID; ARTHRITIS; CASE-CONTROL STUDIES; CHRONIC PAIN; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NEOPLASMS; ODDS RATIO; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; STROKE;

EID: 84883414622     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201303-040OC     Document Type: Article

References (47)

1. NHLBI. Morbidity & mortality: 2009 chart book on cardiovascular, lung, and blood diseases [Internet]. Bethesda, MD: National Heart, Lung, and Blood Institute; 2009 [accessed 2011 Oct 17]. Available from: http://www.nhlbi.nih.gov/resources/docs/2009-ChartBook.pdf.
2. Brault M. Americans with disabilities: 2005. In: current population reports [Internet]. Washington, DC: United States Census Bureau; 2008 Dec. [accessed 2012 Mar 31]. Available from: https://www.census.gov/prod/2008pubs/ p70-117.pdf.
3. GOLD. Global strategy for the diagnosis, management, and prevention of copd, global initiative for chronic obstructive lung disease (GOLD) [Internet]. [updated 2011; accessed 2012 May 8]. Available from: www.goldcopd.org
4. Blinderman CD, Homel P, Billings JA, Tennstedt S, Portenoy RK. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage 2009;38:115-123.
5. Paladini L, Hodder R, Cecchini I, Bellia V, Incalzi RA. The MRC dyspnoea scale by telephone interview to monitor health status in elderly COPD patients. Respir Med 2010;104:1027-1034.
6. Kil SY, Oh WO, Koo BJ, Suk MH. Relationship between depression and health-related quality of life in older Korean patients with chronic obstructive pulmonary disease. J Clin Nurs 2010;19:1307-1314.
7. Bentsen SB, Rustøen T, Miaskowski C. Prevalence and characteristics of pain in patients with chronic obstructive pulmonary disease compared to the Norwegian general population. J Pain 2011;12: 539-545.
8. Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB. Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization. Arch Intern Med 2000;160:2653-2658.
9. Mapel DW, Dutro MP, Marton JP, Woodruff K, Make B. Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data. BMC Health Serv Res 2011;11:43.
10. ATS/ERS. Standards for the diagnosis and management of patients with COPD [Internet]. Version 1.2. [updated 2005 Sept 8; accessed 2012 May 8]. Available from: http://www.thoracic.org/go/copd.
11. Roberts MH, Mapel DW, Hartry A, Von Worley A, Thomson H. Chronic pain among individuals with COPD as compared to other chronic diseases [abstract]. Presented at the American Thoracic Society 2013 International Conference, May 17-22, 2013, Philadelphia, PA. Am J Respir Crit Care Med 2013;187:A5703.
12. Chronic Conditions Data Warehouse. Centers for Medicare and Medicaid (CMS) Chronic Condition Data Warehouse (CCW) condition categories [Internet]. [accessed 2011 Oct 5]. Available from: http://www.ccwdata.org/cs/groups/public/ documents/document/ccw-conditioncategories.pdf.
13. Ethical and independent review services (E&I). Corte Madera, CA [accessed 5 Mar 2013]. Available from: http://www.eandireview.com/
14. Davis J, Robinson R. Le, Xie. Incidence and impact of pain conditions and comorbid illnesses. J Pain Res 2011;4:331-345.
15. ICSI.org. Health care guideline: Assessment and management of chronic pain. Fourth edition [Internet]. Bloomington, MN: Institute for Clinical Systems Improvement. [accessed 2011 Nov 10]. Available from: www.icsi.org.
16. Dagenais S, Caro J, Haldeman S. A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J 2008;8:8-20.
17. Deyo RA, Cherkin D, Conrad D, Volinn E. Cost, controversy, crisis: low back pain and the health of the public. Annu Rev Public Health 1991; 12:141-156.
18. Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factorsfor clinically recognized opioid abuse and dependence among veteransusing opioids for chronic non-cancer pain. Pain 2007;129:355-362.
19. Hagen KB, Holte HH, Tambs K, Bjerkedal T. Socioeconomic factorsand disability retirement from back pain: a 1983-1993 populationbased prospective study in Norway. Spine 2000;25:2480-2487.
20. Vogt MT, Kwoh CK, Cope DK, Osial TA, Culyba M, Starz TW.Analgesic usage for low back pain: impact on health care costs andservice use. Spine 2005;30:1075-1081.
21. Luo X, Pietrobon R, Sun SX, Liu GG, Hey L. Estimates and patterns ofdirect health care expenditures among individuals with back pain inthe United States. Spine 2004;29:79-86.
22. Berner T, Thomson H, Hartry A, Puenpatom RA, Ben-Joseph R,Szeinbach SL. A comparison of daily average consumption ofoxycodone controlled release (oxycontin CR) and oxymorphoneextended release (opana ER) in patients with low back pain. P T2011;36:139-144.
23. Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, MartinBC. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUPstudy. Pain 2008;138:440-449.
24. Boling MC, Padua DA, Marshall SW, Guskiewicz K, Pyne S, Beutler A.A prospective investigation of biomechanical risk factors forpatellofemoral pain syndrome: the Joint Undertaking to Monitor andPrevent ACL Injury (JUMP-ACL) cohort. Am J Sports Med 2009;37:2108-2116.
25. Braden JB, Sullivan MD, Ray GT, Saunders K, Merrill J, Silverberg MJ,Rutter CM, Weisner C, Banta-Green C, Campbell C, et al. Trends inlong-term opioid therapy for noncancer pain among persons witha history of depression. Gen Hosp Psychiatry 2009;31:564-570.
26. Clemens JQ, Meenan RT, O'Keeffe-Rosetti MC, Gao SY, Brown SO,Calhoun EA. Prevalence of prostatitis-like symptoms in a managedcare population. J Urol 2006;176:593-596, discussion 596.
27. Clemens JQ, Meenan RT, Rosetti MC, Gao SY, Calhoun EA.Prevalence and incidence of interstitial cystitis in a managed carepopulation. J Urol 2005;173:98-102, discussion 102.
28. Dominick KL, Ahern FM, Gold CH, Heller DA. Gender differences inNSAID use among older adults with osteoarthritis. AnnPharmacother 2003;37:1566-1571.
29. Gore M, Tai KS, Sadosky A, Leslie D, Stacey BR. Clinicalcomorbidities, treatment patterns, and direct medical costs ofpatients with osteoarthritis in usual care: a retrospective claimsdatabase analysis. J Media Econ 2011;14:497-507.
30. Hermos JA, Young MM, Gagnon DR, Fiore LD. Characterizations oflong-term oxycodone/acetaminophen prescriptions in veteranpatients. Arch Intern Med 2004;164:2361-2366.
31. Khanna R, Smith MJ. Utilization and costs of medical services andprescription medications for rheumatoid arthritis among recipientscovered by a state Medicaid program: a retrospective, crosssectional,descriptive, database analysis. Clin Ther 2007;29:2456-2467.
32. Morasco BJ, Dobscha SK. Prescription medication misuse andsubstance use disorder in VA primary care patients with chronicpain. Gen Hosp Psychiatry 2008;30:93-99.
33. Weir PT, Harlan GA, Nkoy FL, Jones SS, Hegmann KT, Gren LH, LyonJL. The incidence of fibromyalgia and its associated comorbidities:a population-based retrospective cohort study based onInternational Classification of Diseases, 9th Revision codes. J ClinRheumatol 2006;12:124-128.
34. Berger A, Dukes EM, Oster G. Clinical characteristics and economiccosts of patients with painful neuropathic disorders. J Pain 2004;5:143-149.
35. Solomon DH, Avorn J, Wang PS, Vaillant G, Cabral D, Mogun H,Stürmer T. Prescription opioid use among older adults with arthritisor low back pain. Arthritis Rheum 2006;55:35-41.
36. Ryder S-A, Stannard CF. Treatment of chronic pain: antidepressant, antiepileptic and antiarrhythmic drugs. Continuing EducAnaesthesia Crit Care Pain 2005;5:18-21.
37. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measuresfor use with administrative data. Med Care 1998;36:8-27.
38. Healthcare Cost and Utilization Project (HCUP). HCUP comorbiditysoftware [Internet]. Rockville, MD: Agency for Healthcare Researchand Quality [accessed 2013 Apr 15]. Available from:http://www.hcup-us.ahrq.gov/toolssoftware/ comorbidity/comorbidity.jsp.
39. Spiegelman D, Hertzmark E. Easy SAS calculations for risk orprevalence ratios and differences. Am J Epidemiol 2005;162:199-200.
40. Lohne V, Heer HCD, Andersen M, Miaskowski C, Kongerud J, RustøenT. Qualitative study of pain of patients with chronic obstructivepulmonary disease. Heart Lung 2010;39:226-234.
41. Guest JF, Varney SJ, Diggle J. Impact of the British Thoracic Societychronic obstructive pulmonary disease guidelines on patients'health status, healthcare resource use and health-related quality oflife. Prim Care Respir J 2005;14:242-251.
42. Bentsen SB, Rustøen T, Miaskowski C. Differences in subjective andobjective respiratory parameters in patients with chronic obstructivepulmonary disease with and without pain. Int J Chron Obstruct Pulmon Dis 2012;7:137-143.
43. HajGhanbari B, Holsti L, Road JD, Darlene Reid W. Pain in people withchronic obstructive pulmonary disease (COPD). Respir Med 2012;106:998-1005.
44. Katsura H, Yamada K, Wakabayashi R, Kida K. Gender-associated differences in dyspnoea and health-related quality of life in patientswith chronic obstructive pulmonary disease. Respirology 2007;12:427-432.
45. Spencer S, Calverley PM, Sherwood Burge P, Jones PW; ISOLDEStudy Group. Inhaled Steroids in Obstructive Lung Disease. Healthstatus deterioration in patients with chronic obstructive pulmonarydisease. Am J Respir Crit Care Med 2001;163:122-128.
46. Rutten-van Mölken MP, Oostenbrink JB, Tashkin DP, Burkhart D,Monz BU. Does quality of life of COPD patients as measured by thegeneric EuroQol five-dimension questionnaire differentiate betweenCOPD severity stages? Chest 2006;130:1117-1128.
47. Arne M, Lundin F, Boman G, Janson C, Janson S, Emtner M. Factorsassociated with good self-rated health and quality of life in subjectswith self-reported COPD. Int J Chron Obstruct Pulmon Dis 2011;6:511-519.